Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway
Abstract Approximately, 25% of nasopharyngeal carcinoma (NPC) patients develop recurrent disease. NPC may involve relatively few genomic alterations compared to other cancers due to its association with Epstein‐Barr virus (EBV). We envisioned that in‐depth sequencing of tumor tissues might provide n...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2429 |
id |
doaj-f8ef00ee3b1f461d9a6f56fe509e7a7e |
---|---|
record_format |
Article |
spelling |
doaj-f8ef00ee3b1f461d9a6f56fe509e7a7e2020-11-24T21:23:59ZengWileyCancer Medicine2045-76342019-09-018115116512710.1002/cam4.2429Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathwayAn‐Ko Chung0Chun‐Nan OuYang1Hsuan Liu2Mei Chao3Ji‐Dung Luo4Cheng‐Yang Lee5Yen‐Jung Lu6I‐Che Chung7Lih‐Chyang Chen8Shao‐Min Wu9Ngan‐Ming Tsang10Kai‐Ping Chang11Cheng‐Lung Hsu12Hsin‐Pai Li13Yu‐Sun Chang14Graduate Institute of Biomedical Sciences Chang Gung University Taoyuan City Taiwan, Republic of ChinaMolecular Medicine Research Center Chang Gung University Taoyuan City Taiwan, Republic of ChinaGraduate Institute of Biomedical Sciences Chang Gung University Taoyuan City Taiwan, Republic of ChinaGraduate Institute of Biomedical Sciences Chang Gung University Taoyuan City Taiwan, Republic of ChinaMolecular Medicine Research Center Chang Gung University Taoyuan City Taiwan, Republic of ChinaResearch Information Session, Office of Information Technology Taipei Medical University Taipei City Taiwan, Republic of ChinaACT Genomics, Co. Ltd. Taipei City Taiwan, Republic of ChinaGraduate Institute of Biomedical Sciences Chang Gung University Taoyuan City Taiwan, Republic of ChinaDepartment of Medicine Mackay Medical College New Taipei City Taiwan, Republic of ChinaGraduate Institute of Biomedical Sciences Chang Gung University Taoyuan City Taiwan, Republic of ChinaDepartment of Radiation Chang Gung Memorial Hospital Chang Gung University Taoyuan City Taiwan, Republic of ChinaDepartment of Otolaryngology‐Head and Neck Surgery Chang Gung Memorial Hospital Chang Gung University Taoyuan City Taiwan, Republic of ChinaDivision of Hematology‐Oncology, Department of Internal Medicine Chang Gung Memorial Hospital Chang Gung University Taoyuan City Taiwan, Republic of ChinaGraduate Institute of Biomedical Sciences Chang Gung University Taoyuan City Taiwan, Republic of ChinaGraduate Institute of Biomedical Sciences Chang Gung University Taoyuan City Taiwan, Republic of ChinaAbstract Approximately, 25% of nasopharyngeal carcinoma (NPC) patients develop recurrent disease. NPC may involve relatively few genomic alterations compared to other cancers due to its association with Epstein‐Barr virus (EBV). We envisioned that in‐depth sequencing of tumor tissues might provide new insights into the genetic alterations of this cancer. Thirty‐three NPC paired tumor/adjacent normal or peripheral blood mononuclear cell samples were deep‐sequenced (>1000×) with respect to a panel of 409 cancer‐related genes. Newly identified mutations and its correlation with clinical outcomes were evaluated. Profiling of somatic mutations and copy number variations (CNV) in NPC tumors identified alterations in RTK/RAS/PI3K, NOTCH, DNA repair, chromatin remodeling, cell cycle, NF‐κB, and TGF‐β pathways. In addition, patients harbored CNV among 409 cancer‐related genes and missense mutations in TGF‐β/SMAD signaling were associated with poor overall survival and poor recurrence‐free survival, respectively. The CNV events were correlated with plasma EBV copies, while mutations in TGFBR2 and SMAD4 abrogate SMAD‐dependent TGF‐β signaling. Functional analysis revealed that the new TGFBR2 kinase domain mutants were incapable of transducing the signal, leading to failure of phosphorylation of SMAD2/3 and activation of downstream TGF‐β‐mediated cell growth arrest. This study provides evidence supporting CNV and dysregulated TGF‐β signaling contributes to exacerbating the NPC pathogenesis.https://doi.org/10.1002/cam4.2429copy number variationmutationnasopharyngeal carcinomanext‐generation sequencingTGF‐β signaling |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
An‐Ko Chung Chun‐Nan OuYang Hsuan Liu Mei Chao Ji‐Dung Luo Cheng‐Yang Lee Yen‐Jung Lu I‐Che Chung Lih‐Chyang Chen Shao‐Min Wu Ngan‐Ming Tsang Kai‐Ping Chang Cheng‐Lung Hsu Hsin‐Pai Li Yu‐Sun Chang |
spellingShingle |
An‐Ko Chung Chun‐Nan OuYang Hsuan Liu Mei Chao Ji‐Dung Luo Cheng‐Yang Lee Yen‐Jung Lu I‐Che Chung Lih‐Chyang Chen Shao‐Min Wu Ngan‐Ming Tsang Kai‐Ping Chang Cheng‐Lung Hsu Hsin‐Pai Li Yu‐Sun Chang Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway Cancer Medicine copy number variation mutation nasopharyngeal carcinoma next‐generation sequencing TGF‐β signaling |
author_facet |
An‐Ko Chung Chun‐Nan OuYang Hsuan Liu Mei Chao Ji‐Dung Luo Cheng‐Yang Lee Yen‐Jung Lu I‐Che Chung Lih‐Chyang Chen Shao‐Min Wu Ngan‐Ming Tsang Kai‐Ping Chang Cheng‐Lung Hsu Hsin‐Pai Li Yu‐Sun Chang |
author_sort |
An‐Ko Chung |
title |
Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway |
title_short |
Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway |
title_full |
Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway |
title_fullStr |
Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway |
title_full_unstemmed |
Targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the TGF‐β pathway |
title_sort |
targeted sequencing of cancer‐related genes in nasopharyngeal carcinoma identifies mutations in the tgf‐β pathway |
publisher |
Wiley |
series |
Cancer Medicine |
issn |
2045-7634 |
publishDate |
2019-09-01 |
description |
Abstract Approximately, 25% of nasopharyngeal carcinoma (NPC) patients develop recurrent disease. NPC may involve relatively few genomic alterations compared to other cancers due to its association with Epstein‐Barr virus (EBV). We envisioned that in‐depth sequencing of tumor tissues might provide new insights into the genetic alterations of this cancer. Thirty‐three NPC paired tumor/adjacent normal or peripheral blood mononuclear cell samples were deep‐sequenced (>1000×) with respect to a panel of 409 cancer‐related genes. Newly identified mutations and its correlation with clinical outcomes were evaluated. Profiling of somatic mutations and copy number variations (CNV) in NPC tumors identified alterations in RTK/RAS/PI3K, NOTCH, DNA repair, chromatin remodeling, cell cycle, NF‐κB, and TGF‐β pathways. In addition, patients harbored CNV among 409 cancer‐related genes and missense mutations in TGF‐β/SMAD signaling were associated with poor overall survival and poor recurrence‐free survival, respectively. The CNV events were correlated with plasma EBV copies, while mutations in TGFBR2 and SMAD4 abrogate SMAD‐dependent TGF‐β signaling. Functional analysis revealed that the new TGFBR2 kinase domain mutants were incapable of transducing the signal, leading to failure of phosphorylation of SMAD2/3 and activation of downstream TGF‐β‐mediated cell growth arrest. This study provides evidence supporting CNV and dysregulated TGF‐β signaling contributes to exacerbating the NPC pathogenesis. |
topic |
copy number variation mutation nasopharyngeal carcinoma next‐generation sequencing TGF‐β signaling |
url |
https://doi.org/10.1002/cam4.2429 |
work_keys_str_mv |
AT ankochung targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway AT chunnanouyang targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway AT hsuanliu targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway AT meichao targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway AT jidungluo targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway AT chengyanglee targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway AT yenjunglu targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway AT ichechung targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway AT lihchyangchen targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway AT shaominwu targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway AT nganmingtsang targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway AT kaipingchang targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway AT chenglunghsu targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway AT hsinpaili targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway AT yusunchang targetedsequencingofcancerrelatedgenesinnasopharyngealcarcinomaidentifiesmutationsinthetgfbpathway |
_version_ |
1725990177567932416 |